Drug Shortage Report for PREVORA STAGE 1
Report ID | 88123 |
Drug Identification Number | 02046245 |
Brand name | PREVORA STAGE 1 |
Common or Proper name | Chlorhexidine solution |
Company Name | CHX TECHNOLOGIES INC |
Market Status | MARKETED |
Active Ingredient(s) | CHLORHEXIDINE ACETATE |
Strength(s) | 10% |
Dosage form(s) | SOLUTION KIT |
Route of administration | DENTAL |
Packaging size | 6 vials |
ATC code | A01AB |
ATC description | STOMATOLOGICAL PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-28 |
Estimated end date | 2021-11-30 |
Actual end date | 2022-02-07 |
Shortage status | Resolved |
Updated date | 2022-02-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3080 YONGE STREET TORONTO, ONTARIO CANADA M4N 3N1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-02-08 | French | Compare |
v6 | 2022-02-07 | French | Compare |
v5 | 2022-02-07 | English | Compare |
v4 | 2021-08-09 | French | Compare |
v3 | 2021-08-09 | English | Compare |
v2 | 2019-07-02 | French | Compare |
v1 | 2019-07-02 | English | Compare |
Showing 1 to 7 of 7